Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Other Non-Current Assets (2020 - 2025)

Beauty Health (SKIN) has disclosed Other Non-Current Assets for 5 consecutive years, with $2.0 million as the latest value for Q4 2024.

  • On a quarterly basis, Other Non-Current Assets fell 87.53% to $2.0 million in Q4 2024 year-over-year; TTM through Dec 2024 was $2.0 million, a 87.53% decrease, with the full-year FY2024 number at $2.0 million, down 87.53% from a year prior.
  • Other Non-Current Assets was $2.0 million for Q4 2024 at Beauty Health, roughly flat from $2.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $16.1 million in Q2 2023 to a low of $2.0 million in Q3 2024.
  • A 5-year average of $9.2 million and a median of $8.9 million in 2022 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 294.66% in 2022, then plummeted 87.53% in 2024.
  • Beauty Health's Other Non-Current Assets stood at $4.8 million in 2020, then skyrocketed by 39.31% to $6.7 million in 2021, then soared by 111.68% to $14.2 million in 2022, then increased by 13.03% to $16.0 million in 2023, then tumbled by 87.53% to $2.0 million in 2024.
  • Per Business Quant, the three most recent readings for SKIN's Other Non-Current Assets are $2.0 million (Q4 2024), $2.0 million (Q3 2024), and $16.0 million (Q4 2023).